393 related articles for article (PubMed ID: 24630688)
1. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
Robaei D; Carnt N; Minassian DC; Dart JK
Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis.
Carnt N; Robaei D; Watson SL; Minassian DC; Dart JK
Ophthalmology; 2016 May; 123(5):984-90. PubMed ID: 26952591
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors associated with the need for surgical treatments in acanthamoeba keratitis.
Bouheraoua N; Gaujoux T; Goldschmidt P; Chaumeil C; Laroche L; Borderie VM
Cornea; 2013 Feb; 32(2):130-6. PubMed ID: 23132441
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
Tu EY; Joslin CE; Sugar J; Shoff ME; Booton GC
Ophthalmology; 2008 Nov; 115(11):1998-2003. PubMed ID: 18571729
[TBL] [Abstract][Full Text] [Related]
5. Bilateral Acanthamoeba keratitis in Synergeyes contact lens wear: clinical and confocal microscopy findings.
Lee WB; Gotay A
Eye Contact Lens; 2010 May; 36(3):164-9. PubMed ID: 20386314
[TBL] [Abstract][Full Text] [Related]
6.
Carnt N; Robaei D; Minassian DC; Dart JKG
Br J Ophthalmol; 2018 Oct; 102(10):1431-1435. PubMed ID: 29298778
[TBL] [Abstract][Full Text] [Related]
7. Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
Bang S; Edell E; Eghrari AO; Gottsch JD
Am J Ophthalmol; 2010 Jan; 149(1):66-9. PubMed ID: 19875089
[TBL] [Abstract][Full Text] [Related]
8. Resurgence of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation and outcomes.
Patel DV; Rayner S; McGhee CN
Clin Exp Ophthalmol; 2010 Jan; 38(1):15-20; quiz 87. PubMed ID: 20447096
[TBL] [Abstract][Full Text] [Related]
9. Acanthamoeba keratitis: a parasite on the rise.
Thebpatiphat N; Hammersmith KM; Rocha FN; Rapuano CJ; Ayres BD; Laibson PR; Eagle RC; Cohen EJ
Cornea; 2007 Jul; 26(6):701-6. PubMed ID: 17592320
[TBL] [Abstract][Full Text] [Related]
10. The role of topical corticosteroids in the management of Acanthamoeba keratitis.
Park DH; Palay DA; Daya SM; Stulting RD; Krachmer JH; Holland EJ
Cornea; 1997 May; 16(3):277-83. PubMed ID: 9143798
[TBL] [Abstract][Full Text] [Related]
11. Acanthamoeba sclerokeratitis: epidemiology, clinical features, and treatment outcomes.
Iovieno A; Gore DM; Carnt N; Dart JK
Ophthalmology; 2014 Dec; 121(12):2340-7. PubMed ID: 25097155
[TBL] [Abstract][Full Text] [Related]
12. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases.
Khan YA; Kashiwabuchi RT; Martins SA; Castro-Combs JM; Kalyani S; Stanley P; Flikier D; Behrens A
Ophthalmology; 2011 Feb; 118(2):324-31. PubMed ID: 20884060
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acanthamoeba keratitis with intravenous pentamidine before therapeutic keratoplasty.
Sacher BA; Wagoner MD; Goins KM; Sutphin JE; Greiner MA; Kitzmann AS
Cornea; 2015 Jan; 34(1):49-53. PubMed ID: 25255139
[TBL] [Abstract][Full Text] [Related]
14. Acanthamoeba keratitis: clinical characteristics and management.
Jiang C; Sun X; Wang Z; Zhang Y
Ocul Surf; 2015 Apr; 13(2):164-8. PubMed ID: 25881999
[TBL] [Abstract][Full Text] [Related]
15. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis.
Lim N; Goh D; Bunce C; Xing W; Fraenkel G; Poole TR; Ficker L
Am J Ophthalmol; 2008 Jan; 145(1):130-5. PubMed ID: 17996208
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in Acanthamoeba keratitis.
Kaiserman I; Bahar I; McAllum P; Srinivasan S; Elbaz U; Slomovic AR; Rootman DS
Can J Ophthalmol; 2012 Jun; 47(3):312-7. PubMed ID: 22687314
[TBL] [Abstract][Full Text] [Related]
17. The rising tide of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation, diagnosis and outcomes (2009-2016).
McKelvie J; Alshiakhi M; Ziaei M; Patel DV; McGhee CN
Clin Exp Ophthalmol; 2018 Aug; 46(6):600-607. PubMed ID: 29412494
[TBL] [Abstract][Full Text] [Related]
18. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
[TBL] [Abstract][Full Text] [Related]
19.
Papa V; Rama P; Radford C; Minassian DC; Dart JKG
Br J Ophthalmol; 2020 Apr; 104(4):575-581. PubMed ID: 31401556
[TBL] [Abstract][Full Text] [Related]
20. Successful medical treatment of Acanthamoeba keratitis.
Azuara-Blanco A; Sadiq AS; Hussain M; Lloyd JH; Dua HS
Int Ophthalmol; 1997-1998; 21(4):223-7. PubMed ID: 9700010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
